During the past decade, Shenzhen Second People's Hospital conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 1 clinical trials were completed, i.e. on average, 1.5% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 1 clinical trials were completed. i.e. 1.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shenzhen Second People's Hospital" #1 sponsor was "Shenzhen Second People's Hospital" with 25 trials, followed by "Shenzhen People's Hospital" with 8 trials sponsored, "Ascentage Pharma Group Inc." with 3 trials sponsored, "Beijing Tiantan Hospital" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shenzhen Second People's Hospital" #1 collaborator was "Shenzhen Second People's Hospital" with 7 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 3 trials as a collaborator, "Hebei Medical University Fourth Hospital" with 3 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 3 trials as a collaborator and "Affiliated Hospital of Qinghai University" with 2 trials as a collaborator. Other collaborators include 102 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Shenzhen Second People's Hospital" are "Stroke" (5 trials), "Chronic Myeloid Leukemia, Chronic Phase" (3 trials), "Anesthesia" (2 trials), "Breast Cancer" (2 trials) and "Community-acquired Pneumonia" (2 trials). Many other conditions were trialed in "Shenzhen Second People's Hospital" in a lesser frequency.

Most popular intervention types in "Shenzhen Second People's Hospital" are "Drug" (38 trials), "Device" (9 trials), "Other" (8 trials), "Procedure" (8 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Blood sample" (2 trials), "Data collection" (2 trials), "HQP1351" (2 trials) and "Propofol" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shenzhen Second People's Hospital" are 68 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 45 active trials in "Shenzhen Second People's Hospital". 5 are not yet recruiting, 31 are recruiting, 7 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 15 completed trials in Shenzhen Second People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shenzhen Second People's Hospital, 6 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".